Progress and promise for the MDMA drug development program.
Psychopharmacology (Berl) – November 20, 2017
Source: PubMed
Summary
Remarkable progress is being made in developing MDMA as a prescribed medicine. Clinical trials are rigorously evaluating its potential to treat severe mental health conditions, like PTSD, when combined with therapy. The findings consistently demonstrate significant therapeutic benefits and a strong safety profile. This innovative treatment approach holds substantial promise, advancing steadily towards regulatory approval and offering new hope for patients.
Abstract
Progress and promise for the MDMA drug development program.